Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Regeneus Ltd. ( (AU:CMB) ) just unveiled an announcement.
Regeneus Ltd. announced that Barry Sechos has ceased to be a director of Cambium Bio Limited as of May 21, 2025. The final director’s interest notice reveals that Sechos held interests in 14,500 and 62,500 fully paid ordinary shares through Hajivo Pty Ltd and Kirman 2 Pty Ltd, respectively. This change in directorship may impact the company’s governance structure and potentially influence its strategic direction.
More about Regeneus Ltd.
Average Trading Volume: 19,808
Technical Sentiment Signal: Sell
Current Market Cap: A$3.47M
Learn more about CMB stock on TipRanks’ Stock Analysis page.